Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Program Will Improve Blood-Drawing Practices in Africa

By LabMedica International staff writers
Posted on 29 Jun 2010
A joint, multiyear initiative to improve blood collection practices in African clinics and hospitals has been initiated.

The program is designed to protect both health workers and patients in countries severely impacted by the human immunodeficiency virus (HIV)/AIDS pandemic by improving blood collection practices. More...
The initiative ultimately aims to support training for thousands of healthcare workers in sub-Saharan Africa, tracking hundreds of thousands of blood draws per year within each participating country.

In addition, the program will help prevent needlestick injuries by establishing or enhancing needlestick injury surveillance, which will help to identify people in need of life saving post-exposure prophylaxis and correct practices that pose risks to health workers and patients.

Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA) a leading global medical technology company, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) have collaborated to set the joint initiative in motion.

The three-year initiative, which may be extended for up to two additional years, has begun in Kenya under the leadership of the Kenyan Ministries of Health (Nairobi, Kenya) through the National AIDS and STI Control Program. Kenyan health workers will be trained as master trainers in safe blood draw practices. These master trainers will later lead trainings in regions throughout the country. Instructors and trainers from the Kenya Medical Training College (KMTC; Nairobi, Kenya) will participate in the trainings, and help to integrate the information from the program into the College's health-worker training curriculum.

As part of the initiative, BD is funding construction of incinerators at two Kenyan sites to improve their medical waste management. Combined, these efforts will enhance the goal of the Kenya National HIV/AIDS Strategic Plan (KNASP-III) to eliminate HIV transmission in healthcare settings by 2013.

The initiative will expand to include up to four additional PEPFAR-supported countries. PEPFAR and BD are working on the ground with Ministries of Health, national reference laboratories, and various implementing partners. In each participating nation, a technical working group--consisting of the Ministry of Health, CDC, and BD--is developing tailored policies, guidelines, and standard operating procedures for blood drawing and specimen handling.

Related Links:
Becton, Dickinson and Company
U.S. President's Emergency Plan for AIDS Relief
U.S. Department of Health and Human Services' Centers for Disease Control and Prevention
Kenyan Ministries of Health
Kenya Medical Training College



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.